Edoardo Cignoli : Aspen Investment Considers Bid for Vivus

Aspen Investment Fund is considering a nonbinding offer worth $640 million for Vivus, potentially starting a new battle for control of the pharmaceutical firm.



via WSJ.com: US Business http://ift.tt/1mF9PhV